Coffee lovers beware: Hundreds of coffee products are being recalled due to fears that they may be the perfect breeding ground for a potentially deadly toxin. The coffee products were produced by ...
SEOUL, KOREA, April 26, 2024 (GLOBE NEWSWIRE) -- Dr. Eric A. Johnson and Professor Dirk Dressler, internationally renowned botulinum toxin experts, visited South Korea in March this year to join ...
WASHINGTON, Feb. 10, 2022 /PRNewswire/ -- Healis Therapeutics, a privately held biotechnology company, today announces its ownership of a key botulinum toxin patent from AbbVie (NYSE: ABBV). After ...
A Kentucky business admitted using unapproved anti-wrinkle drugs from overseas that resulted in side effects among customers who then faced medical expenses. Facial Expressions, a business in London, ...
Add Yahoo as a preferred source to see more of our stories on Google. Photo: Vanessa Granda Just like we’ve come to casually call all tissues “Kleenex” and every lip balm “ChapStick,” the brand name ...
The Chosun Ilbo on MSN
K-Botox, skinboosters enter Central/South America, Middle East
Domestic bio and medical aesthetic companies are accelerating their expansion into Central and South America and the Middle ...
The agency calls out the "inherent risks" that consumers face when purchasing unapproved or misbranded drugs Catherine Santino is a Style Writer-Reporter at PEOPLE. She began contributing to PEOPLE in ...
Botulinum toxin A (BTX-A) has emerged as an indispensable intervention for managing spasticity in children with cerebral palsy (CP). By inhibiting acetylcholine release at the neuromuscular junction, ...
The US Food and Drug Administration (FDA) has expanded the indiction for daxibotulinumtoxinA-lanm injection (Daxxify, Revance Therapeutics) for the treatment of cervical dystonia in adults, the ...
LONDON--(BUSINESS WIRE)--Technavio has announced the top five leading vendors in their recent global botulinum toxin market report. This research report also lists 23 other prominent vendors that are ...
CHICAGO, IL—The use of botulinum toxin type A in patients undergoing cardiac surgery does not seem to reduce the rate of postoperative atrial fibrillation (AF) overall, according to the phase II NOVA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results